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Abstract We report that the expression of mRNA and the
activity of UDP-glucose:ceramide (Cer) glucosyltransferase-1
(GlcT-1) of human hepatoma Huh7 and mouse melanoma B16
cells increases after treatment with bacterial sphingomyelinase or
upon addition of short-chain Cer. Interestingly, however, GlcT-1
gene transcription was not increased by Cer when GlcT-1 cDNA
was introduced with the CMV promoter in GlcT-1-deficient
GM95 cells, suggesting that the normal promoter region of
GlcT-1 gene is essential for the response. The conversion of C6-
Cer to C6-GlcCer occurred much more rapidly in GlcT-1-
overexpressing Huh7 cells than in mock transfectants. As a
result, GlcT-1-overexpressing cells acquired a greater resistance
to C6-Cer-mediated cell death. ß 2000 Federation of Euro-
pean Biochemical Societies. Published by Elsevier Science
B.V. All rights reserved.
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1. Introduction
Ceramide (Cer) is a common lipid backbone of glycosphin-
golipids (GSLs) and sphingomyelin. Recently, Cer and its
metabolites, sphingosine and sphingosine-1-phosphate, have
emerged as a new class of lipid biomodulator of cell functions
[1^3]. The core structure of the majority of GSLs is glucosyl-
ceramide (GlcCer), which is synthesized on the cytoplasmic
face of the Golgi apparatus by UDP-glucose (Glc):Cer gluco-
syltransferase-1 (GlcT-1). This enzyme is a typical type III
glycosyltransferase and catalyzes the transfer of a Glc residue
from UDP-Glc to Cer [4]. The balance of GSL synthesis and
degradation is completely regulated within the cell but the
mechanism that regulates GSL metabolism still remains to
be elucidated.
Previousl,y we reported that genetic and pharmacological
blockade of GlcT-1 resulted in intracellular accumulation of
Cer [5]. In the present paper, we report that Cer regulates
GlcT-1, thus controlling the content of Cer in human hepa-
toma Huh7 cells and mouse melanoma B16 cells.
2. Materials and methods
2.1. Materials
D-Threo-1-phenyl-2-decanoylamino-3-morpholino-1-propanol
(PDMP) and N-hexanoylsphingosine (C6-Cer) were purchased from
Matreya (USA) and thin-layer chromatography (TLC) plates (silica
gel 60) from Merck (Germany). Sphingomyelinase (SMase) from Ba-
cillus cereus was obtained from Funakoshi Co. (Japan).
[14C]Galactose (Gal) was purchased from Du Pont-New England Nu-
clear (USA), [K-32P]dCTP (6000 Ci/mmol) was obtained from Amer-
sham (USA) and [14C]palmitic acid and [14C]UDP-Glc were from
American Radiolabeled Chemicals (USA). Human GlcT-1 cDNA
was isolated by expression cloning as described in [6]. All other chem-
icals were of the highest grade available.
2.2. Cells
GlcT-1-de¢cient mutant cells, GM95 cells, were obtained from B16
melanoma cells after mutagenesis [7]. GlcT-1 revertant cells, CG1
cells, were generated from GM95 cells by introduction of GlcT-1
cDNA with the cytomegalovirus (CMV) promoter. Human hepatoma
Huh7 cells were kindly donated by Dr. A. Komori, Faculty of Med-
icine, Kyushu University (Japan).
2.3. Cell culture and metabolic labeling
Cells were cultured at 37‡C in minimal essential medium (MEM)
supplemented with 10% fetal bovine serum (FBS) in a humidi¢ed 95%
air, 5% CO2 incubator. For labeling experiments, cells were incubated
in 200 Wl of Dulbecco’s MEM (DMEM) supplemented with 5% FBS
containing 1 WCi of [14C]Gal or 0.5 WCi of [14C]palmitic acid for the
times indicated.
2.4. Extraction and determination of radiolabeled sphingolipids from
cells
Cells (1U105) were harvested by centrifugation at 2000 rpm for
5 min and washed twice with phosphate-bu¡ered saline (PBS). Total
lipids were extracted with 750 Wl of i-propanol/hexane/water
(55:35:10, v/v) with sonication for 20 min. After centrifugation at
13 000 rpm for 5 min, the supernatants obtained were dried under
N2 gas, dissolved in 25 Wl of chloroform/methanol (2:1, v/v), and
applied to TLC plates, which were developed with chloroform/meth-
anol/0.02% CaCl2 (5:4:1, v/v). Radiolabeled GSLs separated on TLC
plates were quanti¢ed using a BAS1500 imaging analyzer (Fuji Film,
Japan). Identi¢cation of C6-GlcCer was performed by the method
described in [8].
2.5. Assay for GlcT-1
GlcT-1 activity shown in Fig. 2C was determined using a radio-
labeled UDP-Glc as a donor according to the method of Basu et al.
[9] with some modi¢cation. To prepare cell lysates, cells were washed
with 1 ml of PBS and suspended in 50 Wl of 10 mM Tris^HCl bu¡er,
pH 7.5, containing 2 mM KCl and 5 mM MgCl2. Standard incuba-
tion mixture (50 Wl) contained 0.5% Triton X-100, 500 WM [14C]UDP-
Glc (0.02 WCi/reaction), 0.3 mM natural Cer (type III, Matrea, USA),
and cell lysate (500 Wg as protein) in 20 mM Tris^HCl bu¡er, pH 7.5.
After incubation at 32‡C for 2 h, 100 Wl of chloroform/methanol (2:1,
v/v) was added to terminate the reaction, and the lower layer was
applied to TLC plates, which were then developed with chloroform/
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methanol/12 mM MgCl2 (65:25:4, v/v). The [14C]GlcCer produced
was detected and quanti¢ed with an imaging analyzer. GlcT-1 activity
shown in Fig. 3A was determined using £uorescent Cer as a donor by
the method described in [5].
50 Wg of C6-NBD-Cer was mixed with 500 Wg of phosphatidylcho-
line and 10 Wg of sulfatide in 1 ml of distilled water to form liposomes.
To prepare cell lysates, cells (5U105) were washed with 1 ml of PBS
and were suspended in 50 Wl of 10 mM Tris^HCl bu¡er, pH 7.5. The
incubation mixture contained 10 Wl of liposomes containing C6-NBD-
Cer, 500 WM UDP-Glc, 1 mM EDTA and cell lysate (50 Wg as pro-
tein) in 50 Wl of 16 mM Tris^HCl bu¡er, pH 7.5. After incubation at
32‡C for 1 h, 100 Wl of chloroform/methanol (2:1, v/v) was added to
terminate the reaction, and the lower layer was applied to TLC plates,
which were then developed with chloroform/methanol/12 mM MgCl2
(65:25:4, v/v). The NBD-GlcCer produced was detected and quanti-
¢ed with a Shimadzu CS-9300 chromatoscanner (excitation 475 nm,
emission 525 nm).
2.6. Cell viability assay
Cell viability was measured using a cell counting kit (Dojindo,
Japan) according to the manufacturer’s instructions. Cells were seeded
on 24-well plates at a density of 5U104 cells/well for 12 h. After
treatment with C6-Cer for an appropriate time, 10 Wl of the cell
counting reagent was added to the culture and the cells were incu-
bated at 37‡C for 30 min. Aliquots of culture were transferred into the
wells of a 96-well plate and measured at 490 nm by a microplate
reader (Bio-Rad, USA).
2.7. Northern blotting analysis
Aliquots of 30 Wg of total RNA were subjected to electrophoresis
on 1% agarose gels containing 18% formaldehyde, and transblotted
onto nylon membranes (Hybond-N, Amersham Pharmacia Biotech,
UK). Nylon membranes were hybridized with 32P-labeled GlcT-1
probe at 42‡C for 24 h. A human L-actin cDNA (Wako Co., Japan)
was used as an internal control.
2.8. Overexpression of GlcT-1
Human hepatoma Huh7 cells (1U105 cells/well) were seeded in a
6-well plate containing MEM in the presence of 10% FBS. After
incubation at 37‡C for 18 h in a CO2 incubator, cells were transfected
with 1 Wg of PIRES-EGFP expression vector (Clontech, USA) alone
or with vector containing GlcT-1 cDNA construct, and 6 Wl of PLUS
reagent plus 4 Wl of LipofectAMINE reagent per well were added
essentially according to the manufacturer’s instructions. After 4 h,
the medium was changed to 2 ml of MEM-K containing 10% FBS
and incubated at 37‡C for the times indicated.
3. Results and discussion
Previously, we reported that genetic or pharmacological
dysfunction of GlcT-1 resulted in the accumulation of Cer
in cells [5]. In this study, we examined the e¡ects of Cer
accumulation on the expression of GlcT-1 mRNA using var-
iants of B16 mouse melanoma cells, GlcT-1-de¢cient mutant
GM95 cells and GlcT-1 revertant CG1 cells, in which the
cDNA encoding GlcT-1 was introduced into GM95 cells
with the CMV promoter. The accumulation of Cer in CG1
cells was found to be much lower than that in GM95 cells but
higher than that in B16 cells after treatment with bacterial
SMase (Fig. 1A). In the presence of PDMP, a potent inhibitor
of GlcT-1 [10], the accumulation of Cer in both CG1 and B16
cells increased markedly after SMase treatment. However,
PDMP had no e¡ect on the Cer content of GlcT-1-de¢cient
GM95 cells after SMase treatment (Fig. 1A). The expression
of GlcT-1 mRNA in B16 cells increased in proportion to the
accumulation of the Cer in the cells (Fig. 1B, left). Interest-
ingly, however, CG1 cells in which the promoter region of the
GlcT-1 gene was replaced by the CMV promoter showed no
increase in the expression of the introduced GlcT-1 mRNA
(Fig. 1B, right), regardless of Cer accumulation (Fig. 1A).
These results indicate that Cer regulates GlcT-1 partly at
the transcriptional step of GlcT-1 synthesis, for which the
normal promoter region of the GlcT-1 gene is essential.
It has been reported that addition of GlcCer stimulates the
cell growth and DNA synthesis of hepatocytes [11], and that
lipopolysaccharides markedly increase the mRNA level of
hepatic GlcT-1 [12]. These observations appear to indicate a
biological role of GlcT-1 in hepatocytes. In this study, we
Fig. 1. The e¡ects of Cer contents on the expression of GlcT-1 mRNA expression in B16 cells, GlcT-1-de¢cient GM95 cells and GlcT-1 rever-
tant CG1 cells. (A) E¡ects of SMase and PDMP on Cer contents. Cells (1U105) were metabolically labeled with 0.5 WCi [14C]palmitic acid for
24 h, washed with fresh DMEM and recultured in DMEM containing 20 mU of SMase from B. cereus for 12 h in the presence or absence of
PDMP (20 WM). Lane 1, control without SMase; 2, treatment with SMase; 3, treatment with SMase in the presence of PDMP. PSL: radioac-
tivity expressed as photo-stimulated luminescence/mm2. (B) E¡ects of Cer contents on GlcT-1 mRNA expression in B16 cells and CG1 cells.
B16 or CG1 cells (6U106) were treated with 500 mU of SMase from B. cereus for 12 h in 5 ml of MEM supplemented with 5% FBS. Total
RNA was isolated from cells using a RNeasy Mini kit (Qiagen, Germany) and analyzed by the method described in Section 2. Lanes: 1, con-
trol experiment without SMase; 2, treatment with SMase; 3, treatment with SMase in the presence of PDMP. The values are the means of du-
plicate determinations.
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examined the e¡ects of Cer on GlcT-1 mRNA expression,
GlcT-1 activity and GlcCer synthesis in human hepatoma
Huh7 cells to clarify whether or not GlcT-1 is regulated by
Cer in liver cells. The content of Cer in the cells was found to
be increased about 7-fold after treatment with a bacterial
SMase (Fig. 2A). GlcT-1 mRNA expression (Fig. 2B),
GlcT-1 activity (Fig. 2C) and GlcCer synthesis (Fig. 2D)
were also increased concomitantly with Cer accumulation.
Addition of C6-Cer to the culture of hepatoma cells also
stimulated transcription of the GlcT-1 gene (Fig. 2B) and
GlcCer synthesis (Fig. 2D). These results indicated that Cer
regulates GSL synthesis in not only mouse melanoma cells but
also human hepatoma cells via activation of GlcT-1, which
occurs partly at the transcriptional step of GlcT-1 synthesis.
Huh7 cells were transfected with the expression vector alone
(mock cells) or with vector containing a GlcT-1 cDNA con-
struct (GlcT-1-overexpressing cells), and then the GlcT-1 ac-
tivities of both cell lysates were examined using C6-NBD-Cer
as an acceptor substrate. As expected, the GlcT-1 activity of
lysates of GlcT-1-overexpressing cells was much higher than
that in lysates of mock cells (Fig. 3A). When C6-Cer was
added to cultures of GlcT-1-overexpressing cells and mock
cells, the short-chain Cer was promptly glycosylated to me-
tabolize C6-GlcCer. It should be noted, however, that the
conversion ratio of C6-Cer to C6-GlcCer in GlcT-1-overex-
pressing cells was much higher than that in mock cells (Fig.
3B). Short-chain Cer is generally toxic to cells when added
exogenously in excess [13]. In fact, cell viability was decreased
by 20% when C6-Cer was added to the culture of Huh7 mock
cells at a concentration of 40 WM, whereas short-chain Cer
treatment did not a¡ect the viability of the GlcT-1-overex-
pressing Huh7 cells at the same concentration (Fig. 3C). These
results showed that Huh7 cells acquired insensitivity to the
short-chain Cer when they overexpressed GlcT-1 possibly
Fig. 2. E¡ects of Cer on GlcT-1 mRNA expression, GlcT-1 activity
and GlcCer synthesis of human hepatoma Huh7 cells. (A) Cer con-
tents. The experiment was conducted as shown in the legend of Fig.
1A. Cont, control experiment without SMase treatment. (B) North-
ern blotting analysis of GlcT-1 mRNA. The experiment was con-
ducted as shown in the legend of Fig. 1B. (C) GlcT-1 activity.
Huh7 cells (4U106) were treated with 500 mU of SMase from B.
cereus in 5 ml of DMEM supplemented with 5% FBS for 12 h.
GlcT-1 activity was measured using [14C]UDP-Glc and a natural
Cer (type III) as described in Section 2. (D) GlcCer synthesis. After
treatment with 20 mU of SMase from B. cereus or 20 WM C6-Cer
for 12 h, Huh7 cells were washed with fresh DMEM and metabol-
ically labeled with 1 WCi of [14C]Gal for 3 h in the same medium
without SMase or C6-Cer. Total lipids were extracted and analyzed
by TLC as described in Section 2. CMH produced was identi¢ed to
be GlcCer, but not GalCer, by borate-impregnated TLC using
chloroform/methanol/water (65:25:3.5, v/v) as described in [17]. The
values in the ¢gure are the means þ S.D. for triplicate determina-
tions. PSL: radioactivity expressed as photo-stimulated lumines-
cence/mm2.
Fig. 3. E¡ects of C6-Cer on GlcT-1-overexpressing human hepato-
ma Huh7 cells. (A) TLC showing GlcT-1 activity of cell lysates us-
ing C6-NBD-Cer as an acceptor. Details are given in Section 2. 1,
C6-NBD-Cer standard; 2, mock transfectants; 3, GlcT-1-overex-
pressing cells. (B) Generation of C6-GlcCer in GlcT-1-overexpress-
ing cells or mock transfectants. GlcT-1-overexpressed cells or mock
transfectants (1U105) were incubated at 37‡C for 3 h in 200 Wl of
DMEM supplemented with 5% FBS containing 1 WCi [14C]Gal and
20 WM C6-Cer. (C) Cell viability of GlcT-1-overexpressing cells or
mock transfectants after treatment with C6-Cer. GlcT-1-overexpress-
ing cells or mock transfectants (5U104) were incubated with 40 WM
C6-Cer at 37‡C for 24 h in 200 Wl of MEM-K supplemented with
10% FBS. Cell viability was determined using a cell counting kit as
described in Section 2. The values are the means þ S.D. for triplicate
determinations.
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due to reduction of the intracellular concentration of short-
chain Cer. It was found that some of the C6-GlcCer produced
by both normal and overexpressing cells was released into the
culture medium (data not shown). It is interesting to note that
cytotoxic resistance to tumor necrosis factor-K, which in-
creases the intracellular Cer content, has been conferred in
human breast cancer cells by introduction of the GlcT-1
gene [14].
The precise mechanism by which the activity of GlcT-1 is
stimulated by Cer is still unknown. In this study, we found
that the promoter region of GlcT-1 is indispensable for tran-
scriptional activation of the GlcT-1 gene by Cer. Recently,
Ichikawa et al. reported the structure of the GlcT-1 gene
and revealed the presence of motifs for the binding sites of
NF-UB, AhR and AP-2 in the promoter region of GlcT-1 [15].
We speculate that GlcT-1 could be stimulated by Cer partly
through the activation of gene transcription by speci¢c fac-
tor(s) such as NF-UB. It is interesting to note that tumor
necrosis factor-K increased the intracellular level of Cer con-
comitantly with activation of NF-UB [16]. GlcT-1 could also
be activated at the post-translational level, since activation of
GlcCer synthesis by Cer was also observed in the presence of
cycloheximide in B16 cells [5].
In summary, we conclude that Cer regulates GlcT-1 partly
at the transcriptional step of GlcT-1 synthesis for which the
promoter region of the GlcT-1 gene is essential, and that
GlcT-1 regulates the content of Cer in cells especially when
Cer is overproduced. However, further studies are needed to
clarify the mechanism by which GlcT-1 is up-regulated by
Cer.
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